about
Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women.Nondaily preexposure prophylaxis for HIV prevention.Distinct Pharmacodynamic Activity of Rilpivirine in Ectocervical and Colonic Explant Tissue.Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model.The Vaginal Microbiome and its Potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women.Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State.Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial Design.Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy.Adolescent pre-exposure prophylaxis for HIV prevention: current perspectives.Nanoparticle-releasing nanofiber composites for enhanced in vivo vaginal retention.Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy.Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir Against Repeated Rectal SHIV Exposures in Macaques.
P2860
Q36443803-D63DC801-C516-48D9-AA5F-F0DFC2B329CEQ36669377-5BAF5B6A-D624-41B0-89CA-2FF5DED5C1C9Q36888077-C342AAD5-46BF-4945-9491-6E5244B493BCQ37143392-26C2BDAF-1C4C-4BFE-9788-4841AD3972A2Q37618260-78E6703F-43B1-44BA-93CC-60D120DE2F73Q38641903-68E7064B-A19F-4BEB-B01D-7D69D99D1015Q38667599-3E348F70-8E33-4AF1-B661-A64691E32D9CQ39488594-FD5F2C7B-9B13-43DC-9537-A7131EC73CFEQ40747185-55CE6707-01B0-40EE-8FE4-3EA789DBA97DQ41926419-B949CB9E-8B19-4E07-8329-1903997A3AD4Q46540207-9BAE55ED-178F-470A-B6B4-E86CF4F25266Q47930607-6F486E10-9D9E-4873-B746-03C92DEFB86CQ52718314-CC35E874-9072-4171-BBDF-C46FEB8DAF0EQ54202671-475BD85E-A594-47AB-B768-50BEE8C402B2
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacokinetics of antiretrovirals in mucosal tissue
@ast
Pharmacokinetics of antiretrovirals in mucosal tissue
@en
type
label
Pharmacokinetics of antiretrovirals in mucosal tissue
@ast
Pharmacokinetics of antiretrovirals in mucosal tissue
@en
prefLabel
Pharmacokinetics of antiretrovirals in mucosal tissue
@ast
Pharmacokinetics of antiretrovirals in mucosal tissue
@en
P2093
P2860
P1476
Pharmacokinetics of antiretrovirals in mucosal tissue
@en
P2093
Angela D M Kashuba
Mackenzie L Cottrell
Nithya Srinivas
P2860
P304
P356
10.1517/17425255.2015.1027682
P407
P577
2015-03-22T00:00:00Z